Distributor Vigilance Obligations Under the MDR

This article outlines the vigilance obligations for medical device distributors within the European Union, as mandated by the Medical Device Regulation (MDR). Distributors play a critical role in the post-market surveillance system, ensuring patient safety and compliance with regulatory requirements.

#Distributor Responsibilities for Vigilance

The Medical Device Regulation (EU) 2017/745 (MDR) assigns specific responsibilities to distributors concerning vigilance. These duties primarily involve reporting incidents and cooperating with manufacturers and competent authorities.

#Reporting Incidents

Distributors must promptly forward any complaints or reports from healthcare professionals, patients, or other users regarding suspected incidents concerning a device they have made available on the market. These reports are forwarded to the manufacturer and, where applicable, to the authorised representative (Article 14(2)(d) MDR).

If distributors consider that a device presents a serious risk, is a falsified device, or has been subject to a significant increase in the frequency of certain incidents, they must immediately inform the manufacturer and the authorised representative (Article 14(4) MDR). They must also inform the competent authority of the Member State where the distributor is established. This ensures timely intervention and appropriate action.

#Cooperation with Authorities

Distributors are obliged to cooperate with competent authorities (Article 14(5) MDR). This includes providing all information and documentation necessary to demonstrate compliance with the MDR. In particular, they must cooperate in any preventive or corrective action taken by the manufacturer or competent authorities.

Where a distributor has provided a device that is subject to field safety corrective action (FSCA), they must cooperate with the manufacturer and competent authorities. This cooperation ensures that the corrective action is effectively implemented and that affected devices are identified and addressed.

#Record Keeping

Distributors must maintain a register of complaints, non-conforming devices, and product recalls and withdrawals (Article 14(2)(d) MDR). This register is essential for traceability and for demonstrating compliance during inspections. It also supports the manufacturer's post-market surveillance system.

#Serious Incidents and Field Safety Corrective Actions

#Definition of a Serious Incident

A "serious incident" is defined in Article 2(65) MDR as any incident that directly or indirectly led, might have led, or might lead to any of the following:

• a patient's, user's, or other person's death,
• a temporary or permanent serious deterioration in a patient's, user's, or other person's state of health,
• a serious public health threat.

Distributors must be able to recognise such incidents and understand their reporting obligations.

#Field Safety Corrective Action (FSCA)

An FSCA is a corrective action taken by a manufacturer for technical or administrative reasons to prevent or reduce the risk of a serious incident in relation to a device already placed on the market (MDCG 2023-3, Section 3.10). Distributors are key stakeholders in the successful implementation of FSCAs. They must ensure that affected devices are identified, quarantined, and returned or modified as per manufacturer instructions.

#EUDAMED and Vigilance

The European database on medical devices, EUDAMED, is central to the MDR's vigilance system. The vigilance module of EUDAMED is intended for the reporting of serious incidents and field safety corrective actions by manufacturers, authorised representatives, and, in some cases, national competent authorities.

Distributors are not direct users for reporting serious incidents in EUDAMED. However, their timely communication to manufacturers and competent authorities is crucial for ensuring that the relevant parties can fulfil their EUDAMED reporting obligations.

It is important to note that the EUDAMED modules have been progressively rolled out. The scope and mandatory use of specific modules may vary. Distributors should confirm the current status and applicable requirements with their national competent authority.

#Table of Distributor Vigilance Obligations

#Common mistakes in practice

• Delay in reporting: Not promptly informing the manufacturer or competent authorities about incidents or serious risks.
• Incomplete information: Providing insufficient details when reporting complaints or incidents, hindering proper investigation.
• Lack of internal procedures: Failing to establish clear internal processes for handling complaints and vigilance reports.
• Ignoring minor incidents: Overlooking incidents deemed 'minor' that, in accumulation, might indicate a systemic issue.
• Insufficient cooperation: Not actively assisting manufacturers or authorities during investigations or recall actions.
• Inadequate record keeping: Failing to maintain comprehensive and accessible records of complaints, non-conformities, and corrective actions.
• Lack of training: Personnel not being adequately trained on vigilance requirements and reporting protocols.

Distributors must integrate vigilance requirements into their quality management systems to ensure continuous compliance and patient safety. Understanding these obligations is fundamental for maintaining market access and fulfilling regulatory responsibilities. For more information on the full device lifecycle, visit EUDAMED AI's lifecycle overview.

This material is for information only and is not legal advice. For binding interpretation consult your national competent authority.